We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$10.7B
Cap. Flow
% of AUM
9.74%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Avg Time Held Equity + Options
0.9
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
1.5
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.17% |
| 2 | Technology | 18.19% |
| 3 | Consumer Discretionary | 12.77% |
| 4 | Healthcare | 10.45% |
| 5 | Financials | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
United Rentals
URI
$64.1B
| $52.8M | 0.05% |
65,202
-119,339
| -65% | -$104M |
2023 Q4
8 quarters
|
|
327
GDS Holdings
GDS
$4.65B
| $52.6M | 0.05% |
1,506,344
+279,141
| +23% | +$9.65M |
2024 Q2
6 quarters
|
|
|
328
Cencora
COR
$65B
| $52.5M | 0.05% |
155,300
-1,839,818
| -92% | -$627M |
2024 Q2
6 quarters
|
|
329
Modine Manufacturing
MOD
$7.86B
| $52.4M | 0.05% |
392,247
+136,398
| +53% | +$20.3M |
2024 Q2
6 quarters
|
|
330
Casey's General Stores
CASY
$25.4B
| $52.3M | 0.05% |
94,681
+70,504
| +292% | +$38.8M |
2025 Q2
2 quarters
|
|
331
Box
BOX
$5.35B
| $52.3M | 0.05% |
1,747,027
+566,302
| +48% | +$17.8M |
2024 Q3
5 quarters
|
|
332
dLocal
DLO
$4.26B
| $51.8M | 0.05% |
3,662,772
+582,718
| +19% | +$8.22M |
2023 Q2
10 quarters
|
|
333
Campbell Soup
CPB
$5.9B
| $51.6M | 0.05% |
1,850,631
+581,625
| +46% | +$17.5M |
2025 Q3
1 quarter
|
|
334
Bruker
BRKR
$8.3B
| $51.5M | 0.05% |
+1,093,816
| New | +$46.2M |
2025 Q4
0 quarters
|
|
335
H&R Block
HRB
$5.89B
| $51.2M | 0.05% |
1,175,635
-22,923
| -2% | -$1.07M |
2025 Q1
3 quarters
|
|
|
OS
336
DELISTED
OneStream Inc
OS
| $51.2M | 0.05% |
2,786,155
+304,238
| +12% | +$5.8M |
2024 Q3
5 quarters
|
|
337
Etsy
ETSY
$7.92B
| $51.1M | 0.05% |
+921,530
| New | +$56.2M |
2025 Q4
0 quarters
|
|
338
PUT
VanEck Junior Gold Miners ETF
GDXJ
$8.06B
| $51M | 0.05% |
448,600
-447,800
| -50% | -$46.3M |
2025 Q1
3 quarters
|
|
339
GFL Environmental
GFL
$18.9B
| $50.3M | 0.05% |
1,170,208
+1,138,865
| +3,634% | +$50.9M |
2023 Q1
11 quarters
|
|
340
Kinder Morgan
KMI
$75.5B
| $49.7M | 0.05% |
1,806,136
-441,366
| -20% | -$11.9M |
2021 Q2
18 quarters
|
|
341
Neurocrine Biosciences
NBIX
$13.8B
| $49.5M | 0.05% |
348,843
+251,554
| +259% | +$36.4M |
2025 Q2
2 quarters
|
|
342
Iris Energy
IREN
$10.7B
| $49.4M | 0.05% |
1,308,065
-724,332
| -36% | -$37.4M |
2023 Q1
11 quarters
|
|
343
DELISTED
Cidara Therapeutics
CDTX
| $49.2M | 0.04% |
222,763
-12,547
| -5% | -$2.03M |
2025 Q2
2 quarters
|
|
344
Inspire Medical Systems
INSP
$2B
| $49M | 0.04% |
531,079
+396,810
| +296% | +$38M |
2024 Q2
6 quarters
|
|
345
Badger Meter
BMI
$3.66B
| $48.9M | 0.04% |
280,157
+88,126
| +46% | +$15.9M |
2024 Q2
6 quarters
|
|
346
FIGS
FIGS
$3.13B
| $48.8M | 0.04% |
4,297,868
+1,712,610
| +66% | +$16M |
2023 Q1
11 quarters
|
|
347
Chime Financial
CHYM
$11.1B
| $48.5M | 0.04% |
1,926,658
+143,308
| +8% | +$3.04M |
2025 Q2
2 quarters
|
|
348
Carnival Corporation Ltd
CCL
$34.8B
| $48.5M | 0.04% |
+1,587,400
| New | +$44.3M |
2025 Q4
0 quarters
|
|
349
Bank of New York Mellon
BNY
$96.5B
| $47.8M | 0.04% |
+412,034
| New | +$45.6M |
2025 Q4
0 quarters
|
|
|
350
PUT
Boston Scientific
BSX
$63.9B
| $47.7M | 0.04% |
+500,000
| New | +$49M |
2025 Q4
0 quarters
|
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $10.7B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.